Jay Reinstein, who suffers from Alzheimer’s, receives an injection so he can have a PET scan at MedStar Georgetown University Hospital in Washington, DC on June 20, 2023. Michael Robinson …
The Food and Drug Administration (FDA) fully approved the Alzheimer’s treatment Leqembi on Thursday, marking a significant expansion in access to the costly drug for older Americans. Medicare announced that …
Another experimental Alzheimer’s drug, donanemab, has been found to modestly slow the progression of the disease in patients by about four to seven months, according to researchers. Eli Lilly and …
The Alzheimer’s drug Leqembi is seen in this undated handout image obtained by Reuters on January 20, 2023. Eisai | via Reuters Medicare has agreed to pay for the Alzheimer’s …
Eli Lilly and Company, Pharmaceutical company headquarters in Alcobendas, Madrid, Spain. Cristina Arias | Cover | Getty Images Eli Lilly on Monday said it applied for full U.S. Food and …